The Aperlena Verdict
Open raceNo supplier dominates: 12 different companies have won the last 13 comparable contracts from this buyer over 5 years. This is a genuinely open race.
Based on 13 comparable awards by this buyer in this sector over 5 years. Every verdict is recorded before the outcome and graded against the award notice. How we score ourselves.
Summary
Machine-generated summaryAOK Sachsen-Anhalt concludes non-exclusive rebate contracts under Section 130a paragraph 8 SGB V for ready-to-use medicines containing the active ingredient lactulose (ATC: A06AD11). The award uses an open-house model with uniform contract terms and a single access procedure, so all eligible and interested pharmaceutical companies or associations of pharmaceutical companies may join at any time on equal conditions. Companies request the participation documents and the contract from the stated contact address and must return them completed and signed. Individual contract negotiations do not take place. The earliest contract start is 1 February 2026, with a maximum duration of 24 months; all contracts end on 31 January 2028. Contracts may terminate early if exclusive rebate contracts are later tendered.
Description
Bid or no-bid?
Six questions before you commit a team. Under each one, what the register holds on it. The answers are yours.
Can I bid?
- Open procedure: any interested supplier may submit a bid. Above the EU threshold: open to companies from any EU country.
- The notice is written in German.
- Certificates from another EU country? Check the equivalents on eCertis
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Report an error in this notice
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 13 hours ago
What this buyer has paid before
Based on 13 comparable contracts this buyer awarded in this sector over the last 4 years.
- Median award
- €1
- Middle half of past awards
- €1 to €1
TED - Tenders Electronic Daily (Publications Office of the EU) publishes no value for this notice, so it has no mark on the scale. The official documents may state one.
Most recent awards
- Medicines - Rebate contract under Section 130a(8) SGB V in conjunction with Section 130c(1) SGB V for the medicines Esperoct (B02BD02), NovoEight (B02BD02) and Alhemo (B02BX10) for the treatment of haemophilia
- Medicines - Discount agreement under § 130a para. 8 SGB V i.V.m. § 130c para. 1 SGB V for the medicines Haemate P (B02BD06) and Voncento (B02BD06) for the treatment of haemophilia
- Pharmaceuticals - Discount agreement under Section 130a(8) SGB V in conjunction with Section 130c(1) SGB V for the medicinal product Factor VIII SDH (B02BD02) for the treatment of haemophilia
- Medicines - Discount agreement under § 130a(8) SGB V i.V.m. § 130c(1) SGB V for Haemoctin SDH (B02BD02) and Haemonine (B02BD04) for haemophilia treatment
- Medicines - Pharmaceutical discount contract under section 130a paragraph 8 SGB V in conjunction with section 130c paragraph 1 SGB V for the medicinal product Fanhdi (B02BD06) for the treatment of haemophilia
Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.
The buyer
Full buyer profileAOK Sachsen - Anhalt
- notices in the register
- 151
- awards
- 45
- awarded in total
- €3.5M
Who wins its contracts
Many suppliers- different companies won its awards
- 21
- of the awards went to the three most frequent winners
- 24%
- of its calls state an estimated value
- 0%
Based on 25 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.
One dot per award, on the day it was signed, sized by its value. A ring is an award with no published value.
Who usually wins this buyer's contracts in this sector
| Company | Wins | Total awarded | Last win |
|---|---|---|---|
| Novartis Pharma GmbH | 2 | Sep 2026 | |
| Bayer Vital GmbH | 1 | Sep 2026 | |
| Biotest GmbH & Co. KGaA | 1 | Sep 2026 | |
| CSL BEHRING GMBH | 1 | Sep 2026 | |
| GlaxoSmithKline GmbH & Co. KG | 1 | May 2026 |
Based on 13 awards with a linked company profile over the last 5 years.
98 open tenders right now
- Sports-related services - Prevention project 'Bewegter Hort' 11 days left
- Maintenance and repair of office machines - Framework contract for consumables, accessories and services for MFPs 11 days left
- Medicines - Medicines containing the active substances tramadol and paracetamol (ATC: N02AJ13) 267 days left
Market context
TED - Tenders Electronic Daily (Publications Office of the EU) publishes no value for this notice, so it cannot be placed among the open notices of its sector. The official documents may state one.
- open now in Medical equipment & pharmaceuticals
- 10,646
- median open notice
- €145,946
Who wins in this market
Many suppliersGermany · Medical equipment & pharmaceuticals
- different companies won awards here
- 808
- of the awards went to the three most frequent winners
- 9%
- buyers awarded contracts here
- 438
Based on 1,507 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.
Similar tenders
Open now
Awarded before
Never miss a tender like this
1,821 new notices in Medical equipment & pharmaceuticals in Germany in the last 7 days. Get an email when new ones appear. Free.
Set up my alert